These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 10352614)

  • 1. BI-RADS categorization as a predictor of malignancy.
    Orel SG; Kay N; Reynolds C; Sullivan DC
    Radiology; 1999 Jun; 211(3):845-50. PubMed ID: 10352614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of benignity or malignancy of a lesion using BI-RADS.
    Masroor I
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):686-8. PubMed ID: 16300702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.
    Liberman L; Abramson AF; Squires FB; Glassman JR; Morris EA; Dershaw DD
    AJR Am J Roentgenol; 1998 Jul; 171(1):35-40. PubMed ID: 9648759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5.
    Fu CY; Hsu HH; Yu JC; Hsu GC; Hsu KF; Chan DC; Ku CH; Lu TC; Chu CH
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S8-13. PubMed ID: 20603785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-aided classification of BI-RADS category 3 breast lesions.
    Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
    Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
    Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
    AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic characteristics and vacuum-assisted breast biopsy (VABB) of non-palpable breast lesions.
    Ventrella V; Tufaro A; Zito FA; Addante M; Stea B; Dentamaro R; D'Amico C; Paradiso A
    Acta Radiol; 2011 Jul; 52(6):602-7. PubMed ID: 21565889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
    Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
    Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of assigning BI-RADS category-3 to breast lesion with respect to follow-up.
    Masroor I
    J Coll Physicians Surg Pak; 2008 Apr; 18(4):209-12. PubMed ID: 18474152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
    Wiratkapun C; Lertsithichai P; Wibulpholprasert B
    J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions.
    Wiratkapun C; Bunyapaiboonsri W; Wibulpolprasert B; Lertsithichai P
    J Med Assoc Thai; 2010 Jul; 93(7):830-7. PubMed ID: 20649064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.
    Baum JK; Hanna LG; Acharyya S; Mahoney MC; Conant EF; Bassett LW; Pisano ED
    Radiology; 2011 Jul; 260(1):61-7. PubMed ID: 21502382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography.
    Kim EK; Ko KH; Oh KK; Kwak JY; You JK; Kim MJ; Park BW
    AJR Am J Roentgenol; 2008 May; 190(5):1209-15. PubMed ID: 18430833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study.
    Sanders MA; Roland L; Sahoo S
    Breast J; 2010; 16(1):28-31. PubMed ID: 19929890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.